197 related articles for article (PubMed ID: 8908098)
21. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I
Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539
[TBL] [Abstract][Full Text] [Related]
22. The influence of intraoperative homologous blood transfusion on prognosis after liver transplantation for hepatocellular carcinoma.
Kaido T; Takada Y; Egawa H; Uemoto S
Hepatogastroenterology; 2009; 56(91-92):808-12. PubMed ID: 19621707
[TBL] [Abstract][Full Text] [Related]
23. [Needle-tract seeding after ultrasound-guided puncture of hepatocellular carcinoma. A study of 150 patients].
Chapoutot C; Perney P; Fabre D; Taourel P; Bruel JM; Larrey D; Domergue J; Ciurana AJ; Blanc F
Gastroenterol Clin Biol; 1999 May; 23(5):552-6. PubMed ID: 10429862
[TBL] [Abstract][Full Text] [Related]
24. [Hepatic resection and transplantation for hepatocellular carcinoma in patients with cirrhosis].
Gugenheim J; Baldini E; Casaccia M; Ouzan D; Saint-Paul MC; Mouiel J
Gastroenterol Clin Biol; 1997; 21(8-9):590-5. PubMed ID: 9587497
[TBL] [Abstract][Full Text] [Related]
25. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.
Tamura S; Kato T; Berho M; Misiakos EP; O'Brien C; Reddy KR; Nery JR; Burke GW; Schiff ER; Miller J; Tzakis AG
Arch Surg; 2001 Jan; 136(1):25-30; discussion 31. PubMed ID: 11146770
[TBL] [Abstract][Full Text] [Related]
26. Liver transplantation for hepatocellular carcinoma: expanding special priority to include stage III disease.
Goodman J; Glasgow SC; Schnitzler M; Lowell JA; Shenoy S; Jendrisak MD; Desai N; Lisker-Melman M; Crippin J; Chapman WC
Arch Surg; 2005 May; 140(5):459-64; discussion 464. PubMed ID: 15897441
[TBL] [Abstract][Full Text] [Related]
27. [Liver transplantation for the treatment of hepatocellular carcinoma].
Chen XG; Zhu XD; Li W; Liu Y; Zou WL; Niu YJ; Wu FD; Guan ZJ; Yue Y
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):628-31. PubMed ID: 17236562
[TBL] [Abstract][Full Text] [Related]
28. [Surgical treatment of hepatocellular carcinoma].
Cherqui D
Ann Chir; 1998; 52(1):79-81. PubMed ID: 9752415
[No Abstract] [Full Text] [Related]
29. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.
Leung JY; Zhu AX; Gordon FD; Pratt DS; Mithoefer A; Garrigan K; Terella A; Hertl M; Cosimi AB; Chung RT
Liver Transpl; 2004 Nov; 10(11):1343-54. PubMed ID: 15497158
[TBL] [Abstract][Full Text] [Related]
30. How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?
Schwartz M; Roayaie S; Llovet J
J Hepatol; 2005 Oct; 43(4):584-9. PubMed ID: 16120468
[No Abstract] [Full Text] [Related]
31. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.
Zimmerman MA; Ghobrial RM; Tong MJ; Hiatt JR; Cameron AM; Hong J; Busuttil RW
Arch Surg; 2008 Feb; 143(2):182-8; discussion 188. PubMed ID: 18283144
[TBL] [Abstract][Full Text] [Related]
32. Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis.
Del Gaudio M; Grazi GL; Principe A; Ravaioli M; Ercolani G; Cescon M; Varotti G; Gardini A; Cavallari A
Hepatogastroenterology; 2004; 51(56):510-4. PubMed ID: 15086193
[TBL] [Abstract][Full Text] [Related]
33. Liver transplantation for primary liver cancer.
Ringe B; Canelo R; Lorf T
Transplant Proc; 1996 Jun; 28(3):1174-5. PubMed ID: 8658616
[No Abstract] [Full Text] [Related]
34. Tumour size is an important predictor for the outcome after liver transplantation for hepatocellular carcinoma.
Löhe F; Angele MK; Gerbes AL; Löhrs U; Jauch KW; Schauer RJ
Eur J Surg Oncol; 2005 Nov; 31(9):994-9. PubMed ID: 16076546
[TBL] [Abstract][Full Text] [Related]
35. Management of hepatocellular carcinoma in New Zealand.
Gane E; McCall J
N Z Med J; 2000 May; 113(1109):172-5. PubMed ID: 10894345
[No Abstract] [Full Text] [Related]
36. Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection--21 plus 13.
Baccarani U; Adani GL; Tavio M; Viale P
Hepatology; 2011 Jun; 53(6):2138; author reply 2138-9. PubMed ID: 21391221
[No Abstract] [Full Text] [Related]
37. Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation?
Colella G; De Carlis L; Rondinara GF; Sansalone CV; Belli LS; Aseni P; Slim AO; Gelosa F; Iamoni GM; Corti A; Mazza E; Arcieri K; Giacomoni A; Minola E; Ideo G; Forti D
Transplant Proc; 1997; 29(1-2):492-4. PubMed ID: 9123098
[No Abstract] [Full Text] [Related]
38. Role of soluble transferrin receptors study in hepatocellular carcinoma with underlying cirrhosis.
Mehta R; Suvarna D; Mustafa CP; Sadasivan S
Indian J Cancer; 2005; 42(4):215. PubMed ID: 16391443
[No Abstract] [Full Text] [Related]
39. Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria.
Zhou J; Wang Z; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY; Fan J
Transplant Proc; 2008 Dec; 40(10):3548-53. PubMed ID: 19100435
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic factors affecting patient survival and tumor recurrence after orthotopic liver transplantation for hepatocellular carcinoma.
Yokoyama I; Sheahan DG; Carr B; Kakizoe S; Selby R; Tzakis AG; Todo S; Iwatsuki S; Starzl TE
Transplant Proc; 1991 Aug; 23(4):2194-6. PubMed ID: 1651577
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
